Top FDA officials said the agency is in the process of removing the black box safety warnings from all forms of menopausal hormone therapy, including creams, pills, and other treatments prescribed to ease the symptoms of menopause and perimenopause. To access this subscriber-only content please log in or subscribe.If your institution has a site license, […]

Cue Biopharma, a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune disease and cancer, and ImmunoScape, a biotechnology company developing next-generation T cell receptor-based therapies in oncology, announced that they have entered into a collaboration and license agreement to advance […]

Limited access to digital resources may be one reason why rural cancer survivors are underrepresented in cancer research, according to researchers at the University of Arkansas for Medical Sciences Institute for Community Health Innovation. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or […]

Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry. To access this subscriber-only content please log in or subscribe.If your institution […]

Thomas J. George, a gastrointestinal medical oncologist and expert in clinical research, has been named interim director of the University of Florida Health Cancer Institute, effective Nov. 17. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all […]

Cornell University has come to an agreement with the Trump administration that will unfreeze the university’s more than $250 million in interrupted federal research funding and “protect Cornell’s students from violations of federal civil rights laws, including from discrimination based on race, sex, or national origin, and promote America’s hardworking farming and rural communities” following […]

FDA has granted full approval of Komzifti (ziftomenib) for adult patients with relapsed or refractory acute myeloid leukemia with a susceptible NPM1 mutation who have no satisfactory alternative treatment options. Komzifti is the first and only once-daily, oral menin inhibitor approved for R/R NPM1-mutated AML, a devastating blood cancer with limited treatment options. To access […]

Rick Pazdur’s appointment as director of the FDA’s Center for Drug Evaluation and Research (CDER) comes at exactly the right moment, both for the agency and for the patients it serves. For more than two decades, I have watched Rick lead with clarity, urgency, and compassion. As the longtime head of FDA’s Oncology Center of […]

The landscape of cancer treatment is rapidly evolving. Increasingly, there is recognition that care must go beyond treating the disease itself—it must also address the whole person and the debilitating symptoms patients experience during and after treatment. Patients with cancer often face 10 to 14 symptoms from diagnosis through treatment and into survivorship or end-of-life […]

With the recent FDA approval of daratumumab for high-risk smoldering multiple myeloma, the moment is ripe to revisit the evolution of our understanding of smoldering multiple myeloma. This development not only underscores the growing recognition of early intervention but also invites a broader reflection on the biological insights and therapeutic strategies that have shaped—and continue […]

Christine M. Lovly will spearhead the development of City of Hope’s new national thoracic oncology program, effective Jan. 1, 2026. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are enrolled in sponsored accounts.Login Subscribe

On the evening of Nov. 12, President Donald Trump signed a continuing resolution that officially ended the 43-day-long U.S. government shutdown that began on Oct. 1. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses […]

Top FDA officials said the agency is in the process of removing the black box safety warnings from all forms of menopausal hormone therapy, including creams, pills, and other treatments prescribed to ease the symptoms of menopause and perimenopause. To access this subscriber-only content please log in or subscribe.If your institution has a site license, […]

Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry. To access this subscriber-only content please log in or subscribe.If your institution […]

Research1 has shown that delivering tumor profiling results to cancer patients prior to initiation of treatment and connecting patients harboring an actionable oncogenic mutation with the right targeted therapy can deliver superior patient outcomes. To fulfill this promise of precision medicine, we need to ensure more targeted therapies are available to patients who need them. […]

At a time when federal immigration policies are becoming stricter, Kunle Odunsi, director of University of Chicago Medicine Comprehensive Cancer Center, reflected on the fact that cancer research is a highly international community. “Iwas born in Nigeria, I grew up in Nigeria, I went to medical school in Nigeria, and then I did some of […]

George F. Tidmarsh has resigned from his job as director of the FDA Center for Drug Evaluation and Research in the aftermath of a lawsuit by a former associate and a probe into what an HHS spokesperson described as “serious concerns about his personal conduct.” To access this subscriber-only content please log in or subscribe.If […]

Richard Pazdur, founding director of FDA’s Oncology Center of Excellence and long-time FDA visionary, has accepted the top job at FDA’s Center for Drug Evaluation and Research following George F. Tidmarsh’s dramatic ouster from the position. This episode is available on Spotify and Apple Podcasts. “This is big. Because, you know, the whole field of […]

The University of Michigan Rogel Cancer has named two new deputy directors and a new associate director to provide strategic leadership in cancer care, research, and training: Michael Deininger, deputy director for team and transdisciplinary research Lesly Dossett, deputy director for clinical innovation and engagement Samuel Kaffenberger, associate director for clinical operations To access this […]

Research1 has shown that delivering tumor profiling results to cancer patients prior to initiation of treatment and connecting patients harboring an actionable oncogenic mutation with the right targeted therapy can deliver superior patient outcomes. To fulfill this promise of precision medicine, we need to ensure more targeted therapies are available to patients who need them. […]

The American Academy of Pediatrics does not recommend the routine use of leucovorin (folinic acid) for autistic children, according to the interim guidance issued by the physician group Oct. 31. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored […]

At a time when federal immigration policies are becoming stricter, Kunle Odunsi, director of University of Chicago Medicine Comprehensive Cancer Center, reflected on the fact that cancer research is a highly international community. “Iwas born in Nigeria, I grew up in Nigeria, I went to medical school in Nigeria, and then I did some of […]

To say that it has been an eventful few months for George Tidmarsh would be a bit of an understatement. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are enrolled in sponsored accounts.Login Subscribe

The Alliance for Clinical Trials in Oncology has named new investigators to leadership roles across its Immuno-Oncology, Radiation Oncology, and Imaging Committees. These accomplished leaders bring expertise spanning immunotherapy, breast, and brain cancers, precision radiotherapy, and advanced imaging technologies. To access this subscriber-only content please log in or subscribe.If your institution has a site license, […]